GO:0003747 | translation release factor activity | 1.38e-06 | 1.35e-02 | 9.668 | 2 | 2 | 2 |
GO:0006479 | protein methylation | 7.57e-05 | 7.39e-01 | 7.209 | 2 | 2 | 11 |
GO:0017148 | negative regulation of translation | 7.16e-04 | 1.00e+00 | 5.624 | 2 | 5 | 33 |
GO:0016149 | translation release factor activity, codon specific | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0006430 | lysyl-tRNA aminoacylation | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0070181 | small ribosomal subunit rRNA binding | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0038066 | p38MAPK cascade | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0004824 | lysine-tRNA ligase activity | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0008609 | alkylglycerone-phosphate synthase activity | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0008611 | ether lipid biosynthetic process | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0006415 | translational termination | 2.59e-03 | 1.00e+00 | 4.691 | 2 | 2 | 63 |
GO:0005654 | nucleoplasm | 2.66e-03 | 1.00e+00 | 2.216 | 5 | 68 | 876 |
GO:0003723 | RNA binding | 2.97e-03 | 1.00e+00 | 3.305 | 3 | 22 | 247 |
GO:0010467 | gene expression | 3.10e-03 | 1.00e+00 | 2.605 | 4 | 49 | 535 |
GO:0001649 | osteoblast differentiation | 3.56e-03 | 1.00e+00 | 4.459 | 2 | 5 | 74 |
GO:0008762 | UDP-N-acetylmuramate dehydrogenase activity | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0090400 | stress-induced premature senescence | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0030529 | ribonucleoprotein complex | 4.35e-03 | 1.00e+00 | 4.311 | 2 | 5 | 82 |
GO:0005515 | protein binding | 4.51e-03 | 1.00e+00 | 0.981 | 10 | 198 | 4124 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 4.56e-03 | 1.00e+00 | 4.276 | 2 | 5 | 84 |
GO:0097452 | GAIT complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 4 |
GO:0006449 | regulation of translational termination | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0006333 | chromatin assembly or disassembly | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 4 |
GO:0004521 | endoribonuclease activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0008610 | lipid biosynthetic process | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 5 |
GO:0051525 | NFAT protein binding | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:1901741 | positive regulation of myoblast fusion | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0030371 | translation repressor activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0005739 | mitochondrion | 6.57e-03 | 1.00e+00 | 2.304 | 4 | 32 | 659 |
GO:0050847 | progesterone receptor signaling pathway | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 6 |
GO:0034063 | stress granule assembly | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 6 |
GO:0010831 | positive regulation of myotube differentiation | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 7 |
GO:0007140 | male meiosis | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 2 | 7 |
GO:0004707 | MAP kinase activity | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 7 |
GO:0004708 | MAP kinase kinase activity | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 2 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 8 |
GO:0019395 | fatty acid oxidation | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 8 |
GO:0071949 | FAD binding | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 4 | 8 |
GO:0032495 | response to muramyl dipeptide | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 8 |
GO:0000398 | mRNA splicing, via spliceosome | 1.03e-02 | 1.00e+00 | 3.668 | 2 | 15 | 128 |
GO:0045663 | positive regulation of myoblast differentiation | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 9 |
GO:0048255 | mRNA stabilization | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 9 |
GO:0005095 | GTPase inhibitor activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0008143 | poly(A) binding | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 10 |
GO:0044822 | poly(A) RNA binding | 1.29e-02 | 1.00e+00 | 2.026 | 4 | 45 | 799 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 4 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0042770 | signal transduction in response to DNA damage | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0042307 | positive regulation of protein import into nucleus | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 3 | 12 |
GO:0051146 | striated muscle cell differentiation | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 12 |
GO:0001502 | cartilage condensation | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 2 | 13 |
GO:0008380 | RNA splicing | 1.68e-02 | 1.00e+00 | 3.302 | 2 | 21 | 165 |
GO:0016597 | amino acid binding | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 14 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 14 |
GO:0016575 | histone deacetylation | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 14 |
GO:0016071 | mRNA metabolic process | 1.77e-02 | 1.00e+00 | 3.259 | 2 | 10 | 170 |
GO:0000188 | inactivation of MAPK activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 15 |
GO:0000166 | nucleotide binding | 1.89e-02 | 1.00e+00 | 3.209 | 2 | 13 | 176 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 16 |
GO:0005782 | peroxisomal matrix | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 16 |
GO:0043022 | ribosome binding | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 2 | 17 |
GO:0045648 | positive regulation of erythrocyte differentiation | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 2 | 17 |
GO:0016070 | RNA metabolic process | 2.14e-02 | 1.00e+00 | 3.114 | 2 | 10 | 188 |
GO:0005737 | cytoplasm | 2.16e-02 | 1.00e+00 | 1.113 | 7 | 127 | 2633 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 18 |
GO:0030316 | osteoclast differentiation | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 18 |
GO:0006378 | mRNA polyadenylation | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 3 | 18 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 18 |
GO:0071346 | cellular response to interferon-gamma | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 20 |
GO:0005720 | nuclear heterochromatin | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 3 | 20 |
GO:0071897 | DNA biosynthetic process | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 20 |
GO:0000077 | DNA damage checkpoint | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 4 | 21 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 21 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 21 |
GO:0051149 | positive regulation of muscle cell differentiation | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 22 |
GO:0002062 | chondrocyte differentiation | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 22 |
GO:0009409 | response to cold | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 22 |
GO:0000049 | tRNA binding | 2.79e-02 | 1.00e+00 | 5.145 | 1 | 2 | 23 |
GO:0008180 | COP9 signalosome | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 6 | 24 |
GO:0071479 | cellular response to ionizing radiation | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 24 |
GO:0008033 | tRNA processing | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 3 | 25 |
GO:0010494 | cytoplasmic stress granule | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 4 | 26 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 1 | 27 |
GO:0042692 | muscle cell differentiation | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 2 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 4 | 29 |
GO:0005778 | peroxisomal membrane | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 3 | 29 |
GO:0007519 | skeletal muscle tissue development | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 2 | 33 |
GO:0007254 | JNK cascade | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 1 | 34 |
GO:0000902 | cell morphogenesis | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 5 | 35 |
GO:0045727 | positive regulation of translation | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 35 |
GO:0031124 | mRNA 3'-end processing | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 4 | 35 |
GO:0009411 | response to UV | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 3 | 36 |
GO:0006369 | termination of RNA polymerase II transcription | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 5 | 38 |
GO:0048511 | rhythmic process | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 5 | 38 |
GO:0006396 | RNA processing | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 4 | 40 |
GO:0000775 | chromosome, centromeric region | 4.93e-02 | 1.00e+00 | 4.311 | 1 | 6 | 41 |
GO:0051403 | stress-activated MAPK cascade | 5.04e-02 | 1.00e+00 | 4.276 | 1 | 2 | 42 |
GO:0006406 | mRNA export from nucleus | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 7 | 44 |
GO:0045892 | negative regulation of transcription, DNA-templated | 5.59e-02 | 1.00e+00 | 2.360 | 2 | 17 | 317 |
GO:0005777 | peroxisome | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 2 | 50 |
GO:0034146 | toll-like receptor 5 signaling pathway | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 3 | 50 |
GO:0034166 | toll-like receptor 10 signaling pathway | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 3 | 50 |
GO:0018105 | peptidyl-serine phosphorylation | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 2 | 51 |
GO:0006338 | chromatin remodeling | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 7 | 55 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 3 | 55 |
GO:0034162 | toll-like receptor 9 signaling pathway | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 3 | 55 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 3 | 55 |
GO:0034134 | toll-like receptor 2 signaling pathway | 6.67e-02 | 1.00e+00 | 3.861 | 1 | 3 | 56 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 6.79e-02 | 1.00e+00 | 3.836 | 1 | 2 | 57 |
GO:0042826 | histone deacetylase binding | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 5 | 58 |
GO:0006935 | chemotaxis | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 2 | 58 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 2 | 58 |
GO:0034138 | toll-like receptor 3 signaling pathway | 7.02e-02 | 1.00e+00 | 3.786 | 1 | 2 | 59 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 7.02e-02 | 1.00e+00 | 3.786 | 1 | 5 | 59 |
GO:0000785 | chromatin | 7.02e-02 | 1.00e+00 | 3.786 | 1 | 6 | 59 |
GO:0007265 | Ras protein signal transduction | 7.02e-02 | 1.00e+00 | 3.786 | 1 | 3 | 59 |
GO:0071013 | catalytic step 2 spliceosome | 7.25e-02 | 1.00e+00 | 3.738 | 1 | 5 | 61 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 7.25e-02 | 1.00e+00 | 3.738 | 1 | 4 | 61 |
GO:0000187 | activation of MAPK activity | 7.48e-02 | 1.00e+00 | 3.691 | 1 | 3 | 63 |
GO:0071222 | cellular response to lipopolysaccharide | 7.59e-02 | 1.00e+00 | 3.668 | 1 | 2 | 64 |
GO:0000922 | spindle pole | 8.05e-02 | 1.00e+00 | 3.581 | 1 | 4 | 68 |
GO:0006928 | cellular component movement | 8.28e-02 | 1.00e+00 | 3.539 | 1 | 6 | 70 |
GO:0030308 | negative regulation of cell growth | 8.28e-02 | 1.00e+00 | 3.539 | 1 | 3 | 70 |
GO:0034142 | toll-like receptor 4 signaling pathway | 8.62e-02 | 1.00e+00 | 3.479 | 1 | 3 | 73 |
GO:0006915 | apoptotic process | 8.83e-02 | 1.00e+00 | 1.985 | 2 | 15 | 411 |
GO:0015630 | microtubule cytoskeleton | 8.84e-02 | 1.00e+00 | 3.440 | 1 | 5 | 75 |
GO:0071456 | cellular response to hypoxia | 8.95e-02 | 1.00e+00 | 3.421 | 1 | 2 | 76 |
GO:0006006 | glucose metabolic process | 9.40e-02 | 1.00e+00 | 3.347 | 1 | 3 | 80 |
GO:0016032 | viral process | 9.46e-02 | 1.00e+00 | 1.927 | 2 | 30 | 428 |
GO:0002224 | toll-like receptor signaling pathway | 9.74e-02 | 1.00e+00 | 3.293 | 1 | 3 | 83 |
GO:0007166 | cell surface receptor signaling pathway | 1.04e-01 | 1.00e+00 | 3.193 | 1 | 3 | 89 |
GO:0044255 | cellular lipid metabolic process | 1.04e-01 | 1.00e+00 | 3.193 | 1 | 2 | 89 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.05e-01 | 1.00e+00 | 1.836 | 2 | 29 | 456 |
GO:0042981 | regulation of apoptotic process | 1.29e-01 | 1.00e+00 | 2.861 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 1.33e-01 | 1.00e+00 | 2.823 | 1 | 8 | 115 |
GO:0003924 | GTPase activity | 1.37e-01 | 1.00e+00 | 2.774 | 1 | 7 | 119 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.43e-01 | 1.00e+00 | 2.703 | 1 | 4 | 125 |
GO:0006184 | GTP catabolic process | 1.49e-01 | 1.00e+00 | 2.646 | 1 | 7 | 130 |
GO:0005759 | mitochondrial matrix | 1.58e-01 | 1.00e+00 | 2.550 | 1 | 7 | 139 |
GO:0030168 | platelet activation | 1.60e-01 | 1.00e+00 | 2.529 | 1 | 5 | 141 |
GO:0044212 | transcription regulatory region DNA binding | 1.62e-01 | 1.00e+00 | 2.509 | 1 | 13 | 143 |
GO:0005622 | intracellular | 1.64e-01 | 1.00e+00 | 2.489 | 1 | 2 | 145 |
GO:0001525 | angiogenesis | 1.65e-01 | 1.00e+00 | 2.479 | 1 | 2 | 146 |
GO:0007165 | signal transduction | 1.74e-01 | 1.00e+00 | 1.397 | 2 | 24 | 618 |
GO:0005634 | nucleus | 1.76e-01 | 1.00e+00 | 0.589 | 6 | 158 | 3246 |
GO:0016020 | membrane | 1.78e-01 | 1.00e+00 | 1.016 | 3 | 56 | 1207 |
GO:0006412 | translation | 1.98e-01 | 1.00e+00 | 2.193 | 1 | 12 | 178 |
GO:0005743 | mitochondrial inner membrane | 2.17e-01 | 1.00e+00 | 2.046 | 1 | 9 | 197 |
GO:0004674 | protein serine/threonine kinase activity | 2.17e-01 | 1.00e+00 | 2.046 | 1 | 8 | 197 |
GO:0005525 | GTP binding | 2.17e-01 | 1.00e+00 | 2.046 | 1 | 12 | 197 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.19e-01 | 1.00e+00 | 2.032 | 1 | 8 | 199 |
GO:0035556 | intracellular signal transduction | 2.19e-01 | 1.00e+00 | 2.032 | 1 | 5 | 199 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.23e-01 | 1.00e+00 | 2.003 | 1 | 14 | 203 |
GO:0030154 | cell differentiation | 2.24e-01 | 1.00e+00 | 1.996 | 1 | 5 | 204 |
GO:0019899 | enzyme binding | 2.30e-01 | 1.00e+00 | 1.954 | 1 | 7 | 210 |
GO:0043231 | intracellular membrane-bounded organelle | 2.37e-01 | 1.00e+00 | 1.900 | 1 | 8 | 218 |
GO:0003682 | chromatin binding | 2.69e-01 | 1.00e+00 | 1.691 | 1 | 15 | 252 |
GO:0008285 | negative regulation of cell proliferation | 2.92e-01 | 1.00e+00 | 1.555 | 1 | 11 | 277 |
GO:0005524 | ATP binding | 3.01e-01 | 1.00e+00 | 0.868 | 2 | 37 | 892 |
GO:0055114 | oxidation-reduction process | 3.19e-01 | 1.00e+00 | 1.402 | 1 | 9 | 308 |
GO:0046872 | metal ion binding | 3.21e-01 | 1.00e+00 | 0.801 | 2 | 24 | 934 |
GO:0007596 | blood coagulation | 3.46e-01 | 1.00e+00 | 1.263 | 1 | 13 | 339 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.47e-01 | 1.00e+00 | 1.255 | 1 | 23 | 341 |
GO:0044267 | cellular protein metabolic process | 3.56e-01 | 1.00e+00 | 1.209 | 1 | 14 | 352 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.77e-01 | 1.00e+00 | 1.110 | 1 | 21 | 377 |
GO:0005783 | endoplasmic reticulum | 3.80e-01 | 1.00e+00 | 1.095 | 1 | 12 | 381 |
GO:0005829 | cytosol | 3.81e-01 | 1.00e+00 | 0.450 | 3 | 88 | 1787 |
GO:0006351 | transcription, DNA-templated | 3.88e-01 | 1.00e+00 | 0.597 | 2 | 47 | 1076 |
GO:0045087 | innate immune response | 4.34e-01 | 1.00e+00 | 0.848 | 1 | 12 | 452 |
GO:0005887 | integral component of plasma membrane | 5.17e-01 | 1.00e+00 | 0.501 | 1 | 8 | 575 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.59e-01 | 1.00e+00 | 0.338 | 1 | 29 | 644 |
GO:0005576 | extracellular region | 5.70e-01 | 1.00e+00 | 0.296 | 1 | 15 | 663 |
GO:0006355 | regulation of transcription, DNA-templated | 5.99e-01 | 1.00e+00 | 0.187 | 1 | 31 | 715 |
GO:0008270 | zinc ion binding | 6.05e-01 | 1.00e+00 | 0.163 | 1 | 39 | 727 |
GO:0070062 | extracellular vesicular exosome | 6.24e-01 | 1.00e+00 | -0.012 | 2 | 51 | 1641 |
GO:0044281 | small molecule metabolic process | 6.62e-01 | 1.00e+00 | -0.053 | 1 | 35 | 844 |
GO:0005730 | nucleolus | 7.98e-01 | 1.00e+00 | -0.581 | 1 | 74 | 1217 |
GO:0005886 | plasma membrane | 9.11e-01 | 1.00e+00 | -1.132 | 1 | 46 | 1784 |